A detailed history of Putnam Investments LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 34,904 shares of ITOS stock, worth $256,544. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,904
Holding current value
$256,544
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$8.57 - $11.06 $299,127 - $386,038
34,904 New
34,904 $382,000
Q2 2022

Aug 15, 2022

SELL
$16.57 - $35.1 $52,410 - $111,021
-3,163 Reduced 8.04%
36,202 $745,000
Q1 2022

May 16, 2022

SELL
$31.92 - $47.45 $93,972 - $139,692
-2,944 Reduced 6.96%
39,365 $1.27 Million
Q4 2021

Feb 14, 2022

BUY
$26.23 - $47.86 $1.11 Million - $2.02 Million
42,309 New
42,309 $1.97 Million

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $261M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.